Wolf Popper represents plaintiffs and defendants in commercial litigation and arbitration arising from significant business conflicts, contract matters, corporate governance issues, and unfair competition claims. We counsel companies, investors, executives, and other stakeholders in high-value disputes that carry operational, financial, and reputational consequences.
We handle domestic and international commercial disputes before state and federal courts across the United States, as well as in leading arbitration forums, including matters governed by the International Chamber of Commerce (ICC), American Arbitration Association (AAA), and UNCITRAL rules.
Business disputes touching on investor rights or market integrity may align with our securities litigation practice. Issues involving corporate governance, Board conduct, and executive decision-making often connect to our corporate transactional and derivative litigation practice.
Our Commercial Litigation & Arbitration practice encompasses:
Corporate governance and fiduciary-related disputes frequently intersect with corporate transactional and derivative litigation.
Wolf Popper advises U.S. and global businesses in arbitration proceedings arising from commercial contracts, strategic joint ventures, licensing, distribution, finance, and supply chain relationships.
Our arbitration capabilities include:
Matters involving digital assets or emerging technologies may also align with our digital assets litigation practice.
Our practice is grounded in thoughtful analysis, discretion, and strategic execution. We tailor our approach to each client’s business priorities, stakeholder considerations, and risk tolerance. We emphasize:
We pursue efficient, commercially sound solutions while maintaining readiness for decisive litigation when circumstances require it.
The most effective dispute strategy often begins before litigation arises. Wolf Popper offers preventive guidance to help clients reduce legal exposure and strengthen their commercial positions.
If you are facing a commercial litigation or arbitration matter, or would value strategic guidance on mitigating business risk, please contact us to discuss the situation and identify the most suitable approach for your objectives.
Firm News | 11/12/2024
Firm News | 10/25/2024
Nearly $1 trillion in private equity funds have gone into almost 8,000 health care transactions over the past decade, according to KFF Health News.
Publications | 06/10/2024
Firm News | 03/27/2024
Case Updates | 02/01/2024
Case Updates | 12/19/2023
Firm News | 11/13/2023
Events | August 13-15, 2023
Events | July 10-12, 2023
Events | May 21–24, 2023
Case Updates | 03/11/2022
Case Updates | 01/25/2021